(NASDAQ:TLRY),(TSX:TLRY), TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today released its 2025 Cannabis Holiday Gift Guide, showcasing Canadians' top picks for gifting, entertaining, and seasonal celebrations. With cannabis […]

(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted four newly-hired employees stock options to purchase an aggregate of 57,100 shares, and restricted stock units (RSUs) covering an aggregate of 46,400 shares, of BioCryst common stock.

(NYSE MKT:PTHS), ZELSUVMI is the first and only FDA-approved at-home treatment for molluscum contagiosum, a highly contagious viral skin condition affecting an estimated 16.7 million people, with up to 6 million new incidents reported every year in the United States DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a

(Other OTC:OTCM),(OTC US:OTCM),(TSX-V:KDK),(Other OTC:KDKCF), NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced KODIAK COPPER CORP. (TSX-V: KDK; OTCQX: KDKCF), focused on the discovery of copper, has qualified to trade on the OTCQX(R) Best Market. KODIAK COPPER

RadioMedix and Thor Medical enter supply agreement for thorium-228 GlobeNewswire December 04, 2025 OSLO, Norway and HOUSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, and RadioMedix, Inc., a U.S. based clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium GlobeNewswire December 04, 2025 SEATTLE, Dec. 04, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that updated data on the

Redpoint Global Named a Leader and Ace Performer in the Spark Matrix (TM): Data Quality & Observability Tools, 2025 by QKS Group GlobeNewswire December 04, 2025 Wellesley MA, Dec. 04, 2025 (GLOBE NEWSWIRE) — QKS Group has named Redpoint Global, The Data Readiness Company, as a Leader and Ace Performer in their SPARK Matrix(TM): Data

Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors GlobeNewswire December 04, 2025 Not for distribution by US newswire or in United States TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company“) (TSX VENTURE: VXL), is pleased to announce that the Company completed its

Plug Power Signs Letter of Intent with Hy2gen for 5MW PEM Electrolyzer Supporting France's Hydrogen Roadmap at Sunrhyse Green Hydrogen Project GlobeNewswire December 04, 2025 Agreement advances renewable, RFNBO-certified hydrogen production in southern France. Partnership supports logistics and mobility decarbonization across the Provence-Alpes-Cote d'Azur region. Project expands Plug's European footprint through collaboration with Hy2gen on

HEROES, HEART & HOPE GALA RAISES OVER $2.4 MILLION TO EXPAND ACCESS TO ADAPTIVE SPORTS, GRANTS AND INCLUSIVE PROGRAMS IN THE NORTHEAST Evening at Casa Cipriani Celebrates Athletes with Physical Disabilities and Raises Critical Funds for Access to Sport GlobeNewswire December 04, 2025 New York, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) — The Challenged Athletes